EKF Diagnostics Holdings PLC Trading update (4295O)
November 07 2016 - 2:00AM
UK Regulatory
TIDMEKF
RNS Number : 4295O
EKF Diagnostics Holdings PLC
07 November 2016
EKF Diagnostics Holdings plc
("EKF", the "Company")
Trading update
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed
point-of-care business, announces that early trading in Q4 of the
current financial year has again been materially higher than budget
and at a run-rate in excess of already revised market forecasts,
upgraded following the trading update provided on 7 October
2016.
The Company now believes that it will achieve revenues of at
least GBP36.5m and adjusted EBITDA for the year ending 31 December
2016 of at least GBP5.5m, therefore exceeding current market
forecasts. The strong performance of the business is due to organic
growth.
In addition, the Company announces that cash generation
continues to be strong and now expects to be close to breakeven if
not cash positive by the year end, and then cash positive in the
first quarter, again ahead of the board's previous
expectations.
The announcement contains inside information for the purposes of
Article 7 of Regulation (EU) No 596/2014.
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Tel: 029 2071 0570
Chairman
Julian Baines, CEO
Richard Evans, FD & COO
Panmure Gordon (UK) Limited Tel: 020 7886 2500
(NOMAD & Joint Broker)
Freddy Crossley / Peter Steel
(Corporate Finance)
N+1 Singer (Joint Broker) Tel: 020 7496 3000
Alex Price / Alex Laughton-Scott
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584
391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTLLFIDLALSIIR
(END) Dow Jones Newswires
November 07, 2016 02:00 ET (07:00 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2023 to Apr 2024